| methyl iodide |
methylation - majority of C-11 radiopharmaceuticals |
| acetone |
isopropylation (beta adrenergics, etc) |
| 3-[C-11]propionaldehyde |
oxidative radical aromatic ethylation |
| Acetate |
cancer esp. prostate, oxidative metab, myocardial infarct |
| Carazolol |
beta-adrenergic receptors |
| choline |
prostate cancer, detection and extent of prostate CA |
| Deprenyl |
MAO-B inhibitor, tracer, Parkinson's, drug metabolism |
| Cocaine |
biodistribution, kinetics, receptor binding |
| Docetaxel |
chemotherapeutic, tumor uptake, prognostic |
| Ethanol |
tracer for ethanol injections, interventional radiology |
| M100907 |
5HT2A receptor occupancy |
| Methionine |
brain tumor, amino acid metabolic rate, BBB |
| Nicotine |
nicotine distribution, pharmacokinetics |
| N-Methyl spiperone |
dopamine and serotonin receptor |
| PK11195 |
Translocator protein (PBR), see FEPPA |
| Raclopride |
dopamine receptor |
| SN38 (Irinotecan) |
chemotherapeutic, tumor uptake measurement |
| Topotecan |
chemotherapeutic, tumor uptake measurement |
| [N-13]ammonia |
myocardial perfusion, other organ perfusion (not brain) |